Abstract
The invention provides an invasive recombinant bacterial cell for use in prevention and/or treatment of an immune-related disorder; said bacterial cell comprising one or more recombinant nucleic acid molecule(s) encoding one or more therapeutic agent(s) for use in prevention and/or treatment of said immune-related disease in a mammal in need thereof.
| Original language | English |
|---|---|
| IPC | A61P 37/ 00 A I |
| Patent number | WO2022008550 |
| Filing date | 07/07/2020 |
| Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
| Priority date | 07/07/2020 |
| Priority number | EP20200184439 |
| Publication status | Published - 13 Jan 2022 |